THE INTERNATIONAL CONSENSUS CLASSIFICATION OF MYELOID AND LYMPHOID NEOPLAMS

The International Consensus Classification of Myeloid and Lymphoid Neoplasms

  • A paraître
"The International Consensus Classification of Myeloid and Lymphoid Neoplasms" provides key information for use at the microscope to assist in arriving at a swift and accurate diagnosis.

Lire la suite keyboard_arrow_right

Auteur(s) Daniel A. Arber, Michael J. Borowitz, James Cook
Éditeur WOLTERS KLUWER
Date 08/02/2025
Pages 768
Taille 27 x 21
Type Relié
ISBN 9781975222598

Description détaillée : The International Consensus Classification of Myeloid and Lymphoid Neoplasms

Developed by 149 experts in the field, "The International Consensus Classification of Myeloid and Lymphoid Neoplasms" provides key information for use at the microscope to assist in arriving at a swift and accurate diagnosis.

Drs. Daniel Arber, Michael J. Borowitz , James Cook, Laurence de Leval, John Goodlad, Robert Hasserjian, Rebecca L. King, Hans-Michael Kvasnicka, and Attilio Orazi lead a team of authors who focus on diagnostic criteria and the clinical significance of each disease entity.

What are the Key Features of "The International Consensus Classification of Myeloid and Lymphoid Neoplasms" ?

 

  • Offers up-to-date information developed through a Clinical Advisory Committee (CAC) process that included the authors and editors of the former 3rd, 4th, and revised 4th edition World Health Organization (WHO) classification of hematopoietic and lymphoid tumors
  • Focuses on diagnostic criteria and includes guidelines as to the clinical significance of each disease authored by a clinician expert
  • Provides essential information for pathologists and hematopathologists in practice and in training, as well as oncologists and hematologists who want to better understand the many disease categories that they encounter

 

Who are the Authors of "The International Consensus Classification of Myeloid and Lymphoid Neoplasms" ?

Daniel Arber, MD, is Professor and Chair of Pathology and specializes in hematopathology. His research interests include the diagnosis and classification of leukemias and lymphomas and tumors of the spleen. He has over 300 publications and book chapters and has authored/edited six medical textbooks.

Dr. Arber is an internationally recognized expert in the diagnosis and classification of hematopoietic tumors, including malignant lymphoma, acute and chronic leukemia, myeloproliferative disorders, myelodysplastic syndrome and tumors of the spleen. University of Chicago, IL, USA

Dr. Michael Borowitz is a professor of pathology and oncology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include the diagnosis of hematologic malignancies. Dr. Borowitz serves as the Executive Deputy Director in the Department of Pathology and also directs the Division of Hematologic Pathology.  He also serves as Deputy Director of Education in the Department of Pathology and is co-director of the Genes to Society curriculum at the Johns Hopkins School of Medicine.

Dr. Borowitz is one of the leaders in applying immunologic techniques to diagnose and classify leukemia and lymphoma. He has published numerous articles documenting the importance of these ancillary studies in accurate diagnosis, and has been particularly active in applying sophisticated approaches using the technique of flow cytometry. He has also been a leader in standardizing the practice of flow cytometry as it applies to leukemia and lymphoma, and has worked on developing improved proficiency testing programs and guidelines as well as good laboratory practice.

À PARAÎTRE OU DERNIÈRE PARUTION DANS LA MÊME CATÉGORIE :

Auteur(s): The International Consensus Classification of Myeloid and Lymphoid Neoplasms

Daniel A. Arber

Du même auteur :

Michael J. Borowitz

Du même auteur :

179,00 €

Bientôt disponible

Expédition dès parution

179,00 €
Alerte disponibilité

Bénéficiez de la remise de 5% en choisissant le retrait en magasin

 
Livraison à 0.01€ à partir de 35€

d'achats en France Métropolitaine

 
Satisfait ou remboursé

sous 14 jours ouvrés

 
Paiements sécurisés

 
Service client

Lundi au Vendredi : de 10h à 18h30
au 04 67 63 62 19 ou par email